IDO1 and neoplasm: We uncover previously reported tumor-immune microenvironment near the tumor-immune boundary enriched for immune cells with high Indoleamine-pyrrole 2,3-dioxygenase (IDO) and Programmed death-ligand 1 (PD-L1) and a novel, immunosuppressed, microenvironment-enriched for cells expressing CD45 and FoxP3.